GIANTT
Groningen Initiative to ANalyse Type 2 diabetes Treatment
Description
General Design
- Cohort type
Clinical cohort
- Design
Longitudinal
- Design description
Dynamic cohort of T2DM patients from various general practices
- Collection type
Retrospective, Prospective
- Start/End year
2004 - ongoing
- Population
Netherlands (the)
- Regions
Groningen
- Number of participants
64000
- Number of participants with samples
0
- Age group at inclusion
Adult (18+ years)
Contact and Contributors
- prof. dr. PD (Petra) Denigp.denig@umcg.nl
Available Data & Samples
Data categories
- Medical records
Areas of information
- Laboratory measures
- Biochemistry
- Hematology
- Microbiology
- Virology
- Immunology
- Toxicology
- Histology
- Genomics
- Other laboratory measures
- Socio-demographic and economic characteristics
- Age/birthdate
- Sex/gender
- Medication and supplements
- Medication and supplement intake
- Physical measures and assessments
- Physical characteristics
- Anthropometry
- Circulation and respiration
- Muscles, skeleton and mobility
- Sensory and pain
- Brain and nerves
- Skin and subcutaneous tissue
- Speech and voice
- Digestion
- Reproduction
- Other physical measures and assessments
Subpopulations
| Name | Description | Number of participants |
|---|
Collection events
| Name | Description | Participants | Start end year |
|---|
Access conditions
- Conditions
health or medical or biomedical research
- Release
Request to be assessed by GIANTT steering committee
- Linkage options
No linkage options.
Funding & Citation requirements
- Citation requirements
This research has been conducted using anonymous data collected from the Groningen Initiative to ANalyse Type 2 diabetes Treatment (GIANTT) database (www.giantt.nl). This longitudinal database contains data from electronic medical records, including prescription data, comorbidity and event data, routine laboratory test results and physical examinations, for patients with type 2 diabetes managed in primary care in the north of the Netherlands (<1% opted out). In The Netherlands, no approval of an ethics committee is needed for studies using anonymous data from medical records.